Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-28T13:59:31.707Z Has data issue: false hasContentIssue false
  • English
  • Français

A study of the prescription and administration of sedative PRN medication to older adults at a secure hospital

Published online by Cambridge University Press:  24 February 2014

Camilla Haw  and
Lindsey Wolstencroft
Camilla Haw*
Affiliation:
School of Health, University of Northampton, Northampton, UK St Andrew's Academic Centre, King's College, London, Institute of Psychiatry, Northampton, UK
Lindsey Wolstencroft
Affiliation:
St Andrew's Healthcare, Northampton, UK
*
Correspondence should be addressed to: Professor Camilla Haw, St Andrew's, Cliftonville, Northampton, NN1 5DG, UK. Phone: +44 (0)1604 616186; Fax: +44 (0)1604 616598. Email: chaw@standrew.co.uk.
Get access

Abstract

Background:

There is a paucity of research into PRN medication use in older psychiatric inpatients. This is an important topic given the risks of polypharmacy, adverse drug reactions, and high dose medication.

Method:

In 2013, we carried out a cross-sectional survey of the prescription and administration of sedative PRN medication to older adult inpatients on seven wards at a UK tertiary referral centre. We compared them with 242 patients of working age.

Results:

Of the 92 patients studied, 56 (60.9%) were prescribed PRN sedation and 25 (27.2%) had received one or more doses in the previous fortnight. In total, 70 doses had been administered; all by mouth and all but one as single doses. Lorazepam was by far the most commonly prescribed and administered PRN drug. Agitation was the main indication, although violence was the most commonly cited reason for administration but documentation of antecedents, non-pharmacological strategies and outcome including side effects was uniformly poor with only 37 (52.9%) doses recorded in the case notes. Those with organic disorders were just as likely to receive PRN as those with functional illnesses. Patients very rarely actually received high dose antipsychotics or antipsychotic polypharmacy as a result of PRN prescriptions. Older patients were less likely than adults of working age to be prescribed PRN and dosages were smaller.

Conclusion:

Prospective studies of PRN prescription and administration are needed to better understand the reasons underpinning its use and to gain objective data upon its effectiveness or otherwise in this vulnerable patient group.

Keywords

as requiredpro re natap.r.npsychotropic medicationolder adultsinpatientspsychiatrymental health
Type
Research Article
Information
International Psychogeriatrics , Volume 26 , Issue 6 , June 2014 , pp. 943 - 951
Copyright
Copyright © International Psychogeriatric Association 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aisen, P. S. and Deluca, T. (1992). Falls among geropsychiatry inpatients are associated with prn medications for agitation. International Journal of Geriatric Psychiatry, 7, 709–712.Google Scholar
Baker, J., Lovell, K. and Harris, N. (2007). Mental health professionals’ psychotropic pro re nata (p.r.n.) medication practices in acute inpatient mental health care: a qualitative study. General Hospital Psychiatry, 29, 163–168.Google Scholar
Baker, J. A., Lovell, K. and Harris, N. (2008). A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settings. Journal of Clinical Nursing, 17, 1122–1131.Google Scholar
Baker, J. A., Keady, J, Hardman, P., Kay, J., Jones, L. and Jolley, D. (2010). Psychotropic PRN use among older people's inpatient mental health services. Journal of Psychiatric and Mental Health Nursing, 17, 463–468.Google Scholar
British Medical Association and Royal Pharmaceutical Society of Great Britain (2012). British National Formulary Number 66. London: BMJ Group and Royal Pharmaceutical Society of Great Britain.Google Scholar
Chakrabarti, A, Whicher, E. V., Morrison, M., and Douglas-Hall, P. (2012). ‘As required’ medication regimens for seriously mentally ill people in hospital. Cochrane Database of Systematic Reviews, doi:10.1002 /14651858.CD003441.pib2.Google Scholar
Corbett, A. and Ballard, C. (2012) Antipsychotics and mortality in dementia. American Journal of Psychiatry, 169, 7–9.Google Scholar
Craven, J. L., Voore, P. M. and Voineskos, G. (1987). PRN medication for psychiatric inpatients. Canadian Journal of Psychiatry, 32, 199–203.Google Scholar
Curtis, J. and Capp, K. (2003). Administration of ‘as needed’ psychotropic medication: a retrospective study. International Journal of Mental Health Nursing, 12, 229–234.CrossRefGoogle ScholarPubMed
Davies, S. J. C., Lennard, M. S., Ghahramani, P., Pratt, P., Robertson, A. and Potokar, J. (2007). PRN prescribing in psychiatric inpatients – potential for pharmacokinetic drug interactions. Journal of Psychopharmacology, 21, 153–548.Google Scholar
Gray, K. F. (2004). Managing agitation and difficult behaviour in dementia. Clinical Geriatric Medicine, 20, 69–82.Google Scholar
Gray, R., Smedley, N. S. and Thomas, B. L. (1996). Administration of PRN medication by mental health nurses. British Journal of Nursing, 5, 1317–1322.Google Scholar
Hilton, M. F. and Whiteford, H. A. (2008). Pro re nata medication for psychiatric inpatients time to act. Australian and New Zealand Journal of Psychiatry, 42, 555–564.Google Scholar
IBM SPSS Inc (2011) SPSS for Windows Version 20 Release 20.0.0. Chicago: IBM SPSS Inc. Google Scholar
Lindsey, P. L. (2009). Psychotropic medication use among older adults: what all nurses need to know. Journal of Gerontological Nursing, 35, 28–38.Google Scholar
Lindsey, P. L. and Buckwalter, K. C. (2012). Administration of PRN medications and use of nonpharmacological interventions in acute geropsychiatric settings: implications for practice. Journal of the American Psychiatric Nurses Association, 18, 82–90.Google Scholar
McIntosh, B., Clark, M. and Spry, C. (2011). Benzodiazepines in Older Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines. Ottawa, Canada: Canadian Agency for Drugs and Technologies in Health.Google ScholarPubMed
McLaren, S., Browne, F. W. A. and Taylor, P. J. (1990). A study of psychotropic medication given ‘as required’ in a regional secure unit. British Journal of Psychiatry, 156, 732–735.Google Scholar
National Institute for Clinical Excellence (2005). The short-term management of disturbed/violent behaviour in inpatient psychiatric settings and emergency departments. Clinical Guideline 25, available at: http://www.guidance.nice.org.uk/CG25.Google Scholar
O'Neil, M. E., Freeman, M., Christensen, V., Telerant, R., Addleman, A. and Kansagara, D. (2011). A Systematic Evidence Review of Non-Pharmacological Interventions for Behavioural Symptoms of Dementia. Washington, DC: Department of Veterans Affairs.Google Scholar
Paton, C., Barnes, T. R. E., Cavanagh, M. R., Taylor, D. and Lelliott, P. (2008). High-dose and combined antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing. British Journal of Psychiatry, 192, 435–439.CrossRefGoogle ScholarPubMed
Schneider, L. S., Dagerman, K. S. and Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia. Journal of the American Medical Association, 294, 1934–1943.Google Scholar
Srivastava, A. (2009). Limited evidence for the effectiveness of P.R.N. medications among psychiatric inpatients. Journal of Psychiatric Practice, 15, 193–201.CrossRefGoogle ScholarPubMed
Stewart, S. A. (2005). The effects of benzodiazepines on cognition. Journal of Clinical Psychiatry, 66, S2, 9–13.Google Scholar
Stewart, D., Robson, D., Chaplin, R, Quirk, A. and Bowers, L. (2012). Behavioural antecedents to pro re nata psychotropic medication administration on acute psychiatric wards. International Journal of Mental Health Nursing, 21, 540–549.Google Scholar
Teodorczuk, A., Reynish, E. and Milisen, K. (2012). Improving recognition of delirium in clinical practice: a call for action. BMC Geriatrics, 12, 55.Google Scholar
Thapa, P. B., Palmer, S. L., Owen, R. R., Huntley, A. L., Clardy, J. A. and Miller, L. H. (2003). P.r.n. (as needed) orders and exposure of psychiatric inpatients to unnecessary psychotropic medications. Psychiatric Services, 54, 1282–1286.Google Scholar
Usher, K., Lindsay, D. and Sellen, J. (2001). Mental health nurses’ PRN psychotropic medication administration practices. Journal of Psychiatric and Mental health Nursing, 8, 383–390.Google Scholar
Van Putten, T., May, P. R. and Marder, S. R. (1984). Akathisia with haloperidol and thiothixene. Archives of General Psychiatry, 41, 1036–9.Google Scholar
Walker, R. (1991). PRN psychotropic drug use on a psychiatric unit. Psychiatric Quarterly, 62, 1–8.Google Scholar
Yorston, G., and Pinney, A. (2000). Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high-dose antipsychotics. Psychiatric Bulletin, 24, 130–2.Google Scholar